NHS Trust Overcharged for Cancer Drug Temozolomide
A major NHS trust has been accused of significantly overcharging for the cancer drug Temozolomide, sparking outrage among patients and healthcare advocates.
A major NHS trust has been accused of significantly overcharging for the cancer drug Temozolomide, sparking outrage among patients and healthcare advocates.